Mr Mrs Miss Ms Dr Other

Mr
Mark
Lunt

Consultant

Sheffield Office

Engineering

Telephone. +44(0) 114 274 3700
Mobile. +44(0) 773 966 7587
Email. mlunt@hgf.com

Experience

40 years since qualifying as a patent attorney, Mark has worked both in industry, firstly in the oil industry with Burmah-Castrol, then in the power tools field with Black & Decker, and in private practice for any client willing to pay! Mark has learned that clients want to know their options, but also to get a positive recommendation on a course of action. This means getting to know your business, and what you are trying to achieve through your intellectual property.

Mark is gregarious and inquisitive, and will get to the bottom of what needs to be done in connection with your IP matters. He will let you know the anticipated costs and, once he has your approval, he will get it done promptly and efficiently. And if Mark can't do it himself, he has a great team of professionals around him to whom he can refer legal, trade mark or other technology areas of patent practice.

Mark handles engineering inventions, but where these have chemical or electronic elements, that is no problem given his broad scientific knowledge. Mark has also developed expertise in handling designs, that is, the appearance of products, as opposed to what they do.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Oceanography and Zoology

CSR

Mark is a director of Pamia Limited, which is the mutual insurance company run by the patent profession and which insures 97% of the patent and trade mark attorney profession in the United Kingdom.

The company indemnifies HGF, and all insured members, against claims that may be made when things go wrong. Unfortunately, this is just a fact of life, and despite the best endeavours of any firm or individual, mistakes do occasionally get made which can result in losses for our clients.

With assets in excess of £20million, and close links with the insurance markets, Pamia provides a first layer of insurance for its members, with excess layers provided by the general insurance market. The Board of Directors is made up of individuals from members firms who are advised by the managers of Pamia, namely Thomas Miller Professional Indemnity Limited, who manage several mutual insurance companies. The Board, however, takes full responsibility for the company, including claims management as well as the investment of its assets.

Mark is Chair of the Rules & Terms of Cover committee, and a member of the Investment committee, both committees being answerable to the Board.

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.